位置:首页 > 蛋白库 > NRP2_MOUSE
NRP2_MOUSE
ID   NRP2_MOUSE              Reviewed;         931 AA.
AC   O35375; B1AT44; O35373; O35374; O35376; O35377; O35378;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 179.
DE   RecName: Full=Neuropilin-2;
DE   AltName: Full=Vascular endothelial cell growth factor 165 receptor 2;
DE   Flags: Precursor;
GN   Name=Nrp2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A0; A17; A22; A5; B0 AND B5).
RC   STRAIN=BALB/cJ;
RX   PubMed=9331348; DOI=10.1016/s0896-6273(00)80371-2;
RA   Chen H., Chedotal A., He Z.-G., Goodman C.S., Tessier-Lavigne M.;
RT   "Neuropilin-2, a novel member of the neuropilin family, is a high affinity
RT   receptor for the semaphorins Sema E and Sema IV but not Sema III.";
RL   Neuron 19:547-559(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, and Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: High affinity receptor for semaphorins 3C, 3F, VEGF-165 and
CC       VEGF-145 isoforms of VEGF, and the PLGF-2 isoform of PGF.
CC   -!- SUBUNIT: Heterodimer with NRP1. Binds PLXNB1 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:O60462}; Single-
CC       pass type I membrane protein {ECO:0000250|UniProtKB:O60462}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=A22;
CC         IsoId=O35375-1; Sequence=Displayed;
CC       Name=A0;
CC         IsoId=O35375-2; Sequence=VSP_004344;
CC       Name=A5;
CC         IsoId=O35375-3; Sequence=VSP_004345;
CC       Name=A17;
CC         IsoId=O35375-4; Sequence=VSP_004343;
CC       Name=B0;
CC         IsoId=O35375-5; Sequence=VSP_004346;
CC       Name=B5;
CC         IsoId=O35375-6; Sequence=VSP_004347;
CC   -!- TISSUE SPECIFICITY: Expressed in developing CNS, PNS and in some
CC       nonneural tissues including limb buds, developing bones, muscles,
CC       intestinal epithelium, kidney, lung and submandibular gland.
CC   -!- DEVELOPMENTAL STAGE: The expression pattern is very dynamic and is
CC       developmentally regulated.
CC   -!- DOMAIN: The tandem CUB domains mediate binding to semaphorin, while the
CC       tandem F5/8 domains are responsible for heparin and VEGF binding.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the neuropilin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF022856; AAC53379.1; -; mRNA.
DR   EMBL; AF022854; AAC53377.1; -; mRNA.
DR   EMBL; AF022855; AAC53378.1; -; mRNA.
DR   EMBL; AF022857; AAC53380.1; -; mRNA.
DR   EMBL; AF022858; AAC53381.1; -; mRNA.
DR   EMBL; AF022861; AAC53382.1; -; mRNA.
DR   EMBL; AL645727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL671560; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS14995.1; -. [O35375-3]
DR   CCDS; CCDS35589.1; -. [O35375-1]
DR   CCDS; CCDS35590.1; -. [O35375-4]
DR   CCDS; CCDS35591.1; -. [O35375-2]
DR   CCDS; CCDS35592.1; -. [O35375-6]
DR   CCDS; CCDS35593.1; -. [O35375-5]
DR   RefSeq; NP_001070871.1; NM_001077403.1. [O35375-1]
DR   AlphaFoldDB; O35375; -.
DR   SMR; O35375; -.
DR   BioGRID; 201849; 12.
DR   STRING; 10090.ENSMUSP00000109794; -.
DR   GlyGen; O35375; 4 sites.
DR   iPTMnet; O35375; -.
DR   PhosphoSitePlus; O35375; -.
DR   SwissPalm; O35375; -.
DR   CPTAC; non-CPTAC-3486; -.
DR   MaxQB; O35375; -.
DR   PaxDb; O35375; -.
DR   PeptideAtlas; O35375; -.
DR   PRIDE; O35375; -.
DR   ProteomicsDB; 293740; -. [O35375-1]
DR   ProteomicsDB; 293741; -. [O35375-2]
DR   ProteomicsDB; 293742; -. [O35375-3]
DR   ProteomicsDB; 293743; -. [O35375-4]
DR   ProteomicsDB; 293744; -. [O35375-5]
DR   ProteomicsDB; 293745; -. [O35375-6]
DR   ABCD; O35375; 5 sequenced antibodies.
DR   Antibodypedia; 34173; 448 antibodies from 35 providers.
DR   DNASU; 18187; -.
DR   Ensembl; ENSMUST00000027112; ENSMUSP00000027112; ENSMUSG00000025969. [O35375-6]
DR   Ensembl; ENSMUST00000063594; ENSMUSP00000069379; ENSMUSG00000025969. [O35375-4]
DR   Ensembl; ENSMUST00000075144; ENSMUSP00000074642; ENSMUSG00000025969. [O35375-3]
DR   Ensembl; ENSMUST00000102822; ENSMUSP00000099886; ENSMUSG00000025969. [O35375-2]
DR   Ensembl; ENSMUST00000114155; ENSMUSP00000109792; ENSMUSG00000025969. [O35375-5]
DR   Ensembl; ENSMUST00000114157; ENSMUSP00000109794; ENSMUSG00000025969. [O35375-1]
DR   GeneID; 18187; -.
DR   KEGG; mmu:18187; -.
DR   UCSC; uc007bfj.1; mouse. [O35375-6]
DR   UCSC; uc007bfl.1; mouse. [O35375-1]
DR   UCSC; uc007bfn.1; mouse. [O35375-3]
DR   UCSC; uc007bfo.1; mouse. [O35375-2]
DR   CTD; 8828; -.
DR   MGI; MGI:1100492; Nrp2.
DR   VEuPathDB; HostDB:ENSMUSG00000025969; -.
DR   eggNOG; ENOG502QVB7; Eukaryota.
DR   GeneTree; ENSGT00940000155270; -.
DR   HOGENOM; CLU_015228_6_1_1; -.
DR   InParanoid; O35375; -.
DR   OMA; XYDFIEI; -.
DR   PhylomeDB; O35375; -.
DR   TreeFam; TF316506; -.
DR   Reactome; R-MMU-194306; Neurophilin interactions with VEGF and VEGFR.
DR   BioGRID-ORCS; 18187; 2 hits in 72 CRISPR screens.
DR   ChiTaRS; Nrp2; mouse.
DR   PRO; PR:O35375; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; O35375; protein.
DR   Bgee; ENSMUSG00000025969; Expressed in vault of skull and 268 other tissues.
DR   ExpressionAtlas; O35375; baseline and differential.
DR   Genevisible; O35375; MM.
DR   GO; GO:0030424; C:axon; IDA:MGI.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0017154; F:semaphorin receptor activity; IDA:MGI.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0005021; F:vascular endothelial growth factor receptor activity; IEA:InterPro.
DR   GO; GO:0001525; P:angiogenesis; IEA:InterPro.
DR   GO; GO:0048846; P:axon extension involved in axon guidance; IMP:BHF-UCL.
DR   GO; GO:0007411; P:axon guidance; IMP:MGI.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEP:MGI.
DR   GO; GO:1904835; P:dorsal root ganglion morphogenesis; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0021612; P:facial nerve structural organization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1903375; P:facioacoustic ganglion development; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0021828; P:gonadotrophin-releasing hormone neuronal migration to the hypothalamus; IMP:BHF-UCL.
DR   GO; GO:0007507; P:heart development; IGI:MGI.
DR   GO; GO:0050919; P:negative chemotaxis; IMP:MGI.
DR   GO; GO:0021675; P:nerve development; IMP:BHF-UCL.
DR   GO; GO:1901166; P:neural crest cell migration involved in autonomic nervous system development; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0001764; P:neuron migration; IMP:BHF-UCL.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; IGI:BHF-UCL.
DR   GO; GO:0099175; P:regulation of postsynapse organization; IDA:SynGO.
DR   GO; GO:1902285; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; IMP:BHF-UCL.
DR   GO; GO:0097374; P:sensory neuron axon guidance; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0061549; P:sympathetic ganglion development; IMP:BHF-UCL.
DR   GO; GO:0097490; P:sympathetic neuron projection extension; IMP:BHF-UCL.
DR   GO; GO:0097491; P:sympathetic neuron projection guidance; IMP:BHF-UCL.
DR   GO; GO:0061551; P:trigeminal ganglion development; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0036484; P:trunk neural crest cell migration; IMP:MGI.
DR   GO; GO:0036486; P:ventral trunk neural crest cell migration; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0021649; P:vestibulocochlear nerve structural organization; IMP:ParkinsonsUK-UCL.
DR   CDD; cd00041; CUB; 2.
DR   CDD; cd00057; FA58C; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.120.290; -; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR014648; Neuropilin.
DR   InterPro; IPR027143; Neuropilin-2.
DR   InterPro; IPR022579; Neuropilin_C.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   PANTHER; PTHR46806:SF2; PTHR46806:SF2; 1.
DR   Pfam; PF00431; CUB; 2.
DR   Pfam; PF11980; DUF3481; 1.
DR   Pfam; PF00754; F5_F8_type_C; 2.
DR   Pfam; PF00629; MAM; 1.
DR   PIRSF; PIRSF036960; Neuropilin; 1.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   SMART; SM00042; CUB; 2.
DR   SMART; SM00231; FA58C; 2.
DR   SMART; SM00137; MAM; 1.
DR   SUPFAM; SSF49785; SSF49785; 2.
DR   SUPFAM; SSF49854; SSF49854; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS01180; CUB; 2.
DR   PROSITE; PS01285; FA58C_1; 2.
DR   PROSITE; PS01286; FA58C_2; 2.
DR   PROSITE; PS50022; FA58C_3; 2.
DR   PROSITE; PS50060; MAM_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Developmental protein; Differentiation;
KW   Disulfide bond; Glycoprotein; Heparin-binding; Membrane; Metal-binding;
KW   Neurogenesis; Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..931
FT                   /note="Neuropilin-2"
FT                   /id="PRO_0000021864"
FT   TOPO_DOM        21..864
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        865..889
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        890..931
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..142
FT                   /note="CUB 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          149..267
FT                   /note="CUB 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          277..427
FT                   /note="F5/8 type C 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00081"
FT   DOMAIN          434..592
FT                   /note="F5/8 type C 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00081"
FT   DOMAIN          642..802
FT                   /note="MAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00128"
FT   REGION          298..317
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          601..621
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          819..854
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        836..851
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         197
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:O60462"
FT   BINDING         211
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:O60462"
FT   BINDING         252
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:O60462"
FT   CARBOHYD        152
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        157
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        629
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        839
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        28..55
FT                   /evidence="ECO:0000250|UniProtKB:O60462"
FT   DISULFID        83..105
FT                   /evidence="ECO:0000250|UniProtKB:O60462"
FT   DISULFID        149..175
FT                   /evidence="ECO:0000250|UniProtKB:O60462"
FT   DISULFID        208..230
FT                   /evidence="ECO:0000250|UniProtKB:O60462"
FT   DISULFID        277..427
FT                   /evidence="ECO:0000250|UniProtKB:O60462"
FT   DISULFID        434..592
FT                   /evidence="ECO:0000250|UniProtKB:O60462"
FT   VAR_SEQ         809..830
FT                   /note="Missing (in isoform A0)"
FT                   /evidence="ECO:0000303|PubMed:9331348"
FT                   /id="VSP_004344"
FT   VAR_SEQ         809..813
FT                   /note="Missing (in isoform A17)"
FT                   /evidence="ECO:0000303|PubMed:9331348"
FT                   /id="VSP_004343"
FT   VAR_SEQ         810..931
FT                   /note="EDFKVDIPETHGGEGYEDEIDDEYEGDWSNSSSSTSGAGDPSSGKEKSWLYT
FT                   LDPILITIIAMSSLGVLLGATCAGLLLYCTCSYSGLSSRSCTTLENYNFELYDGLKHKV
FT                   KINHQKCCSEA -> GTLPPGTEPTVDTVPVQPIPAYWYYVMAAGGAVLVLASVVLALV
FT                   LHYHRFRYAAKKTDHSITYKTSHYTNGAPLAVEPTLTIKLEQERGSHC (in
FT                   isoform B0)"
FT                   /evidence="ECO:0000303|PubMed:9331348"
FT                   /id="VSP_004346"
FT   VAR_SEQ         814..931
FT                   /note="VDIPETHGGEGYEDEIDDEYEGDWSNSSSSTSGAGDPSSGKEKSWLYTLDPI
FT                   LITIIAMSSLGVLLGATCAGLLLYCTCSYSGLSSRSCTTLENYNFELYDGLKHKVKINH
FT                   QKCCSEA -> GGTLPPGTEPTVDTVPVQPIPAYWYYVMAAGGAVLVLASVVLALVLHY
FT                   HRFRYAAKKTDHSITYKTSHYTNGAPLAVEPTLTIKLEQERGSHC (in isoform
FT                   B5)"
FT                   /evidence="ECO:0000303|PubMed:9331348"
FT                   /id="VSP_004347"
FT   VAR_SEQ         814..830
FT                   /note="Missing (in isoform A5)"
FT                   /evidence="ECO:0000303|PubMed:9331348"
FT                   /id="VSP_004345"
FT   CONFLICT        32
FT                   /note="L -> P (in Ref. 1; AAC53377/AAC53378/AAC53379/
FT                   AAC53380/AAC53381/AAC53382)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        786
FT                   /note="I -> G (in Ref. 1; AAC53377/AAC53378/AAC53382)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   931 AA;  104631 MW;  08AA821E696A2885 CRC64;
     MDMFPLTWVF LALYFSGHEV RSQQDPPCGG RLNSKDAGYI TSPGYPQDYP SHQNCEWIVY
     APEPNQKIVL NFNPHFEIEK HDCKYDFIEI RDGDSESADL LGKHCGNIAP PTIISSGSVL
     YIKFTSDYAR QGAGFSLRYE IFKTGSEDCS KNFTSPNGTI ESPGFPEKYP HNLDCTFTIL
     AKPRMEIILQ FLTFDLEHDP LQVGEGDCKY DWLDIWDGIP HVGPLIGKYC GTKTPSKLRS
     STGILSLTFH TDMAVAKDGF SARYYLIHQE PPENFQCNVP LGMESGRIAN EQISASSTFS
     DGRWTPQQSR LHGDDNGWTP NLDSNKEYLQ VDLRFLTMLT AIATQGAISR ETQKGYYVKS
     YKLEVSTNGE DWMVYRHGKN HKIFQANNDA TEVVLNKLHM PLLTRFIRIR PQTWHLGIAL
     RLELFGCRVT DAPCSNMLGM LSGLIADTQI SASSTREYLW SPSAARLVSS RSGWFPRNPQ
     AQPGEEWLQV DLGTPKTVKG VIIQGARGGD SITAVEARAF VRKFKVSYSL NGKDWEYIQD
     PRTQQTKLFE GNMHYDTPDI RRFDPVPAQY VRVYPERWSP AGIGMRLEVL GCDWTDSKPT
     VETLGPTVKS EETTTPYPMD EDATECGENC SFEDDKDLQL PSGFNCNFDF PEETCGWVYD
     HAKWLRSTWI SSANPNDRTF PDDKNFLKLQ SDGRREGQYG RLISPPVHLP RSPVCMEFQY
     QAMGGHGVAL QVVREASQES KLLWVIREDQ GSEWKHGRII LPSYDMEYQI VFEGVIGKGR
     SGEISIDDIR ISTDVPLENC MEPISAFAGE DFKVDIPETH GGEGYEDEID DEYEGDWSNS
     SSSTSGAGDP SSGKEKSWLY TLDPILITII AMSSLGVLLG ATCAGLLLYC TCSYSGLSSR
     SCTTLENYNF ELYDGLKHKV KINHQKCCSE A
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024